| Hans-Günter Meyer-Thompson | Hepatitiden
Country versus pharmaceutical company interests for hepatitis C treatment.
Country versus pharmaceutical company interests for hepatitis C treatment.
Lothan R, Gutman N, Yamin D.
Health Care Manag Sci. 2022 Aug 24:1–25. doi: 10.1007/s10729-022-09607-2. Epub ahead of print. PMID: 36001218; PMCID: PMC9399601.